| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-, sex- and disease subtype–related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysis
|
Karalexi, Maria A.
|
|
|
130 |
C |
p. 1-11
|
artikel
|
| 2 |
A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015
|
van der Kaaij, Rosa T.
|
|
|
130 |
C |
p. 23-31
|
artikel
|
| 3 |
A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors
|
Atallah, Sarah
|
|
|
130 |
C |
p. 241-249
|
artikel
|
| 4 |
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients
|
Zlobec, Inti
|
|
|
130 |
C |
p. 139-145
|
artikel
|
| 5 |
Atypical extended immune-related neutropenia in patient treated with pembrolizumab
|
Laurain, Pierre-Antoine
|
|
|
130 |
C |
p. 269-271
|
artikel
|
| 6 |
Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors
|
Romanski, Nicole A.
|
|
|
130 |
C |
p. 211-218
|
artikel
|
| 7 |
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial
|
Onda, Takashi
|
|
|
130 |
C |
p. 114-125
|
artikel
|
| 8 |
Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programme
|
Groenland, Stefanie L.
|
|
|
130 |
C |
p. 32-38
|
artikel
|
| 9 |
Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer
|
Klinkhammer-Schalke, Monika
|
|
|
130 |
C |
p. 102-113
|
artikel
|
| 10 |
Diffuse large B-cell lymphoma after nivolumab treatment for lung cancer: A case report and a World Health Organization pharmacovigilance database review
|
Boudou-Rouquette, Pascaline
|
|
|
130 |
C |
p. 20-22
|
artikel
|
| 11 |
Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial
|
Zheng, Yanan
|
|
|
130 |
C |
p. 12-19
|
artikel
|
| 12 |
Emergency presentations in patients treated with immune checkpoint inhibitors
|
Cooksley, Tim
|
|
|
130 |
C |
p. 193-197
|
artikel
|
| 13 |
Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial’ [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]
|
Hammel, Pascal
|
|
|
130 |
C |
p. 275-276
|
artikel
|
| 14 |
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
|
Facchinetti, Francesco
|
|
|
130 |
C |
p. 155-167
|
artikel
|
| 15 |
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
|
Cohen, Romain
|
|
|
130 |
C |
p. 63-71
|
artikel
|
| 16 |
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infection
|
Lee, Po-Hsin
|
|
|
130 |
C |
p. 272-274
|
artikel
|
| 17 |
Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor–induced secondary adrenal insufficiency
|
Yano, Seiichi
|
|
|
130 |
C |
p. 198-203
|
artikel
|
| 18 |
Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium
|
Leroy, Roos
|
|
|
130 |
C |
p. 81-91
|
artikel
|
| 19 |
Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial
|
Kim, Jin Won
|
|
|
130 |
C |
p. 51-62
|
artikel
|
| 20 |
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials
|
Werutsky, Gustavo
|
|
|
130 |
C |
p. 92-101
|
artikel
|
| 21 |
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial
|
Slagter, Astrid E.
|
|
|
130 |
C |
p. 146-154
|
artikel
|
| 22 |
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy
|
Ferrari, Andrea
|
|
|
130 |
C |
p. 72-80
|
artikel
|
| 23 |
Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer
|
Kilpeläinen, Tuomas P.
|
|
|
130 |
C |
p. 204-210
|
artikel
|
| 24 |
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
|
Lok, Christianne
|
|
|
130 |
C |
p. 228-240
|
artikel
|
| 25 |
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer
|
Kim, Richard D.
|
|
|
130 |
C |
p. 219-227
|
artikel
|
| 26 |
Re: A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
|
Pashankar, Farzana
|
|
|
130 |
C |
p. 265-266
|
artikel
|
| 27 |
Re: Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images
|
Géraud, Cyrill
|
|
|
130 |
C |
p. 259-261
|
artikel
|
| 28 |
Reply to the letter to the editor: ‘Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images’
|
Hekler, Achim
|
|
|
130 |
C |
p. 262-264
|
artikel
|
| 29 |
Response to: A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
|
Berney, Daniel M.
|
|
|
130 |
C |
p. 267-268
|
artikel
|
| 30 |
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
|
Yang, Jianliang
|
|
|
130 |
C |
p. 182-192
|
artikel
|
| 31 |
Should a neck dissection be performed on patients with cN0 adenoid cystic carcinoma? A REFCOR propensity score matching study
|
Atallah, Sarah
|
|
|
130 |
C |
p. 250-258
|
artikel
|
| 32 |
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
|
Ugurel, Selma
|
|
|
130 |
C |
p. 126-138
|
artikel
|
| 33 |
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers
|
Schubert, Nil A.
|
|
|
130 |
C |
p. 168-181
|
artikel
|
| 34 |
The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study
|
Michot, Jean-Marie
|
|
|
130 |
C |
p. 39-50
|
artikel
|
Tijdschrift beschrijving